Roosa Jokela

Roosa Jokela

Auto-generated profile, based on publicly available information

Roosa Jokela

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
BHBrandon Hickman
Brandon Hickman
ASAnne Salonen
Anne Salonen
Alise J. PonseroAlise J. Ponsero
Alise J. Ponsero
RJRoosa Jokela
Roosa Jokela
KKKaija-Leena Kolho
Kaija-Leena Kolho
KKKatri Korpela
Katri Korpela
The human gut microbiota is central in regulating all facets of host physiology, and in early life it is thought to influence the host’s immune system and metabolism, affecting long-term health. However, longitudinally monitored cohorts with parallel analysis of faecal samples and health data are scarce. In our observational study we describe the gut microbiota development in the first 2 years of life and create a gut microbiota wellbeing index based on the microbiota development and health data in a cohort of nearly 1000 infants using clustering and trajectory modelling. We show that infants’ gut microbiota development is highly predictable, following one of five trajectories, dependent on infant exposures, and predictive of later health outcomes. We characterise the natural healthy gut microbiota trajectory and several different dysbiotic trajectories associated with different health outcomes. Bifidobacterium and Bacteroides appear as early keystone organisms, directing microbiota development and consistently predicting positive health outcomes. A microbiota wellbeing index, based on the healthy development trajectory, is predictive of general health over the first 5 years. The results indicate that gut microbiota succession is part of infant physiological development, predictable, and malleable. This information can be utilised to improve the predictions of individual health risks.

1 July 2023 in EBioMedicine
Verified
Journal Article
Open access
RJRoosa Jokela
Roosa Jokela
Alise J. PonseroAlise J. Ponsero
Alise J. Ponsero
EDEvgenia Dikareva
Evgenia Dikareva
XWXiaodong Wei
Xiaodong Wei
KKKaija-Leena Kolho
Kaija-Leena Kolho
ASAnne Salonen
Anne Salonen
Although the infant gut microbiota has been extensively studied, comprehensive assessment on the microbiota determinants including technical variables has not been performed in large infant cohorts. We studied the effect of 109 variables on the 16S rRNA gene amplicon-based gut microbiota profiles of infants sampled longitudinally from three weeks to two years of life in the Finnish HELMi birth cohort. Spot faecal samples from both parents were included for intra-family analyses, totalling to 7657 samples from 985 families that were evaluated for beta-diversity patterns using permutational multivariate analysis on Bray–Curtis distances, and differential abundance testing and alpha-diversity for variables of interest. We also assessed the effect of different taxonomic levels and distance methods. In time point-specific models, the largest share of variation explained, up to 2–6%, were seen in decreasing order for the DNA extraction batch, delivery mode and related perinatal exposures, defecation frequency and parity/siblings. Variables describing the infant gastrointestinal function were continuously important during the first two years, reflecting changes in e.g., feeding habits. The effect of parity/siblings on infant microbiota was modified by birth mode and exposure to intrapartum antibiotics, exemplifying the tight interlinkage of perinatal factors relevant for infant microbiota research. In total, up to 19% of the biological microbiota variation in the infant gut could be explained. Our results highlight the need to interpret variance partitioning results in the context of each cohort's characteristics and microbiota processing. Our study provides a comprehensive report of key factors associated with infant gut microbiota composition across the two first years of life in a homogenous cohort. The study highlights possible important future research areas and confounding factors to be considered. This research was supported by 10.13039/501100014438 Business Finland , 10.13039/501100002341 Academy of Finland , Foundation for Nutrition Research and the Doctoral Program in Microbiology and Biotechnology, University of Helsinki, Finland.

14 August 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
JCJohannes Cairns
Johannes Cairns
RJRoosa Jokela
Roosa Jokela
JHJenni Hultman
Jenni Hultman
MTManu Tamminen
Manu Tamminen
MVMarko Virta
Marko Virta
THTeppo Hiltunen
Teppo Hiltunen
Experimental microbial ecology and evolution have yielded foundational insights into ecological and evolutionary processes using simple microcosm setups and phenotypic assays with one- or two-species model systems. The fields are now increasingly incorporating more complex systems and exploration of the molecular basis of observations. For this purpose, simplified, manageable and well-defined multispecies model systems are required that can be easily investigated using culturing and high-throughput sequencing approaches, bridging the gap between simpler and more complex synthetic or natural systems. Here we address this need by constructing a completely synthetic 33 bacterial strain community that can be cultured in simple laboratory conditions. We provide whole-genome data for all the strains as well as metadata about genomic features and phenotypic traits that allow resolving individual strains by amplicon sequencing and facilitate a variety of envisioned mechanistic studies. We further show that a large proportion of the strains exhibit coexistence in co-culture over serial transfer for 48 days in the absence of any experimental manipulation to maintain diversity. The constructed bacterial community can be a valuable resource in future experimental work.

10 August 2020 in Nature Ecology & Evolution
Verified
Journal Article
Closed access
PDF file
JCJohannes Cairns
Johannes Cairns
RJRoosa Jokela
Roosa Jokela
LBLutz Becks
Lutz Becks
VMVille Mustonen
Ville Mustonen
THTeppo Hiltunen
Teppo Hiltunen

30 October 2018 in mSystems
Verified
Journal Article
Open access
PDF file
JCJohannes Cairns
Johannes Cairns
KKKatariina Koskinen
Katariina Koskinen
RPReetta Penttinen
Reetta Penttinen
TPTommi Patinen
Tommi Patinen
AHAnna Hartikainen
Anna Hartikainen
MJMatti Jalasvuori
Matti Jalasvuori
Bacterial antibiotic resistance is often a part of mobile genetic elements that move from one bacterium to another. By interfering with the horizontal movement and the maintenance of these elements, it is possible to remove the resistance from the population. Here, we show that a so-called plasmid-dependent bacteriophage causes the initially resistant bacterial population to become susceptible to antibiotics. However, this effect is efficiently countered when the system also contains a predator that feeds on bacteria. Moreover, when the environment contains antibiotics, the survival of resistance is dependent on the resistance mechanism. When bacteria can help their contemporaries to degrade antibiotics, resistance is maintained by only a fraction of the community. On the other hand, when bacteria cannot help others, then all bacteria remain resistant. The concentration of the antibiotic played a less notable role than the antibiotic used. This report shows that the survival of antibiotic resistance in bacterial communities represents a complex process where many factors present in real-life systems define whether or not resistance is actually lost.

28 April 2022 in Gut Microbiome
Verified
Journal Article
Open access
PDF file
MPMarie-Luise Puhlmann
Marie-Luise Puhlmann
RJRoosa Jokela
Roosa Jokela
KDKatja Catharina Wilhelmina van Dongen
Katja Catharina Wilhelmina van Dongen
NBNam Bui
Nam Bui
RHRoland Willem Jan van Hangelbroek
Roland Willem Jan van Hangelbroek
EFEdith Feskens
Edith Feskens
We investigated the impact of dried chicory root in a randomised, placebo-controlled trial with 55 subjects at risk for type 2 diabetes on bowel function, gut microbiota and its products, and glucose homeostasis. The treatment increased stool softness (+1.1 ± 0.3 units; p = 0.034) and frequency (+0.6 ± 0.2 defecations/day; p < 0.001), strongly modulated gut microbiota composition (7 % variation; p = 0.001), and dramatically increased relative levels (3-4-fold) of Anaerostipes and Bifidobacterium spp., in a dose-dependent, reversible manner. A synthetic community, including selected members of these genera and a Bacteroides strain, generated a butyrogenic trophic chain from the product. Faecal acetate, propionate and butyrate increased by 25.8 % (+13.0 ± 6.3 mmol/kg; p = 0.023) as did their fasting circulating levels by 15.7 % (+7.7 ± 3.9 μM; p = 0.057). In the treatment group the glycaemic coefficient of variation decreased from 21.3 ± 0.94 to 18.3 ± 0.84 % (p = 0.004), whereas fasting glucose and HOMA-ir decreased in subjects with low baseline Blautia levels (−0.3 ± 0.1 mmol/L fasting glucose; p = 0.0187; −0.14 ± 0.1 HOMA-ir; p = 0.045). Dried chicory root intake rapidly and reversibly affects bowel function, benefits butyrogenic trophic chains, and promotes glycaemic control.